FDA.reportPublic FDA data

Jaythari 22.75 MG/ML Oral Suspension

RxCUI
2727381
RxNorm name
Jaythari 22.75 MG/ML Oral Suspension
Display name
Jaythari 22.75 MG/ML Oral Suspension
Full name
Jaythari 22.75 MG/ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JAYTHARI Oral SuspensionDEFLAZACORTZydus Pharmaceuticals (USA) Inc.abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa92026-07-23Warnings, Adverse reactionsExact identifier
rxcui: 2727381

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa9Jaythari 22.75 MG/ML Oral SuspensionSY1These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI . JAYTHARI (deflazacort) oral suspension Initial U.S. Approval: 201720251114
abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa9deflazacort 22.75 MG/ML Oral Suspension [Jaythari]SBD1These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI . JAYTHARI (deflazacort) oral suspension Initial U.S. Approval: 201720251114
abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa9JAYTHARI 22.75 MG/mL Oral SuspensionPSN1These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI . JAYTHARI (deflazacort) oral suspension Initial U.S. Approval: 201720251114